Work

Enlicitide (Lipfendra) – An Oral PCSK9 Inhibitor for LDL-Cholesterol Lowering

Year: 2026

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2026.1762a

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7203990631

FWCI:

Cites:

Cited by:

Related to: